Evidence map›Paper›PMID 35404942›Full record

ArticlePloS one2022

Exposure to arsenic and level of Vitamin D influence the number of Th17 cells and production of IL-17A in human peripheral blood mononuclear cells in adults.

Faruque Parvez, Fredine T Lauer, Pam Factor-Litvak, Tariqul Islam, Mahbubul Eunus, M Abu Horayara, Mizanour Rahman, Golam Sarwar, Habibul Ahsan, Joseph H Graziano and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Faruque ParvezDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, United States of America.ORCID 0000-0002-5079-3825
Fredine T LauerDepartment of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, United States of America.ORCID 0000-0002-5460-4606
Pam Factor-LitvakDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Tariqul IslamUniversity of Chicago and Columbia University Field Research Office, Dhaka, Bangladesh.
Mahbubul EunusUniversity of Chicago and Columbia University Field Research Office, Dhaka, Bangladesh.
M Abu HorayaraUniversity of Chicago and Columbia University Field Research Office, Dhaka, Bangladesh.
Mizanour RahmanUniversity of Chicago and Columbia University Field Research Office, Dhaka, Bangladesh.
Golam SarwarUniversity of Chicago and Columbia University Field Research Office, Dhaka, Bangladesh.
Habibul AhsanDepartment of Health Studies, University of Chicago, Chicago, Illinois, United States of America.
Joseph H GrazianoDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Scott W BurchielDepartment of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, United States of America.ORCID 0000-0001-9509-0149
University of Chicago Research Bangladesh · BDColumbia University · USUniversity of New Mexico · USUniversity of Chicago · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Synergistic Immunosuppression by PAHs and ArseniteR01ES019968 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BURCHIEL, SCOTT W · 2012 to 2016
$2.9M
Arsenic Exposure, Impaired Respiratory Function, and ImmunosuppressionR01ES023888 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARVEZ, MUHAMMAD F · 2015 to 2018
$1.8M
Perkin-Elmer NexION-300D Inductively Coupled Mass Spectrometer (ICP-MS)S10OD016384 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRAZIANO, JOSEPH H · 2014 to 2014
$181k
NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P30 ES027792NIEHS NIH HHS P42 ES010349NIEHS NIH HHS R01 ES019968NIEHS NIH HHS R01 ES023888NIH HHS S10 OD016384
6 · The paper itself

Abstract

There is limited evidence on the effects of environmental exposure to arsenic (As) on the immune system in adults. In a population-based study, we have found that urinary As (UAs), and its metabolites [inorganic As (InAs), monomethylated arsenicals (MMA+3/+5), and dimethylated arsenicals (DMA+3/+5)] modulate or influence the number of T-helper 17 (Th17) cells and IL-17A cytokine production. In non-smoking women, we observed that UAs and DMA+3/+5 were associated with changes in Th17 cell numbers in a nonlinear fashion. In smoking males, we found that UAs was associated with a significant decrease of Th17 cell numbers. Similar association was observed among non-smoking males. Likewise, UAs, DMA+3/+5 and MMA+3/+5 were associated with diminished production of IL-17A among non-smoking males. When stratified by Vitamin D levels defined as sufficient (≥20 ng/ml) and insufficient (<20 ng/ml), we found a substancial decrease in Th17 cell numbers among those with insufficient levels. Individuals with sufficient VitD levels demonstrated significant inhibition of IL-17A production in non-smoking males. Collectively, we find that exposure to As via drinking water is associated with alterations in Th17 numbers and IL-17A production, and that these associations may be modified by Vitamin D status. Our findings have significance for health outcomes associated with As exposure.

Indexed as

ArsenicArsenicalsAdultEnvironmental ExposureFemaleHumansInterleukin-17Leukocytes, MononuclearMaleTh17 CellsVitamin DVitaminsArsenicArsenicalsInterleukin-17Vitamin DVitamins

Identifiers

PMID35404942
PMCPMC9000092
OpenAlexW4223643206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.